drugset / Trial / NCT01653756

A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects

NCT01653756

Phase 2 Completed 50 enrolled SecuraBio
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to examine the effects of multi-dose regimens of IPI-145 on lung function in mild asthmatic subjects following allergen challenge.

Timeline

Start
2012-07
Primary completion
2014-08
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duvelisib Small molecule

Indications